Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.

@article{Bhm2015TwentyfourhourHR,
  title={Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.},
  author={Michael B{\"o}hm and Jeffrey S. Borer and John Camm and Ian Ford and Suzanne M. Lloyd and Michel Komajda and Luigi Tavazzi and Mario Talajic and Mitja Lain{\vs}{\vc}ak and Jan-Christian Reil and Christian Ukena and Karl Swedberg},
  journal={European journal of heart failure},
  year={2015},
  volume={17 5},
  pages={
          518-26
        }
}
AIMS Analysis of 24-h Holter recordings was a pre-specified substudy of SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial) for exploring the heart rhythm safety of ivabradine and to determine effects of ivabradine on 24-h, daytime, and night-time heart rate (HR) compared with resting office HR. METHODS AND RESULTS The 24-h Holter monitoring was performed at baseline and 8 months after randomization to ivabradine (n = 298) or matching placebo (n = 304) titrated… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Ivabradine for the Treatment of Cardiovascular Diseases.

Advances in the management of heart failure: the role of ivabradine

VIEW 1 EXCERPT
CITES METHODS

Vagal Nerve Stimulation Evoked Heart Rate Changes and Protection from Cardiac Remodeling

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES